Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/10/028746
CTRI/2020/10/028746
Not yet recruiting
未知

To evaluate the safety and efficacy of Ayurvedic Interventions and Analysis of Gut Flora in the cases of Amavata vis-à-vis Rheumatoid Arthritis.

AMRIT GODBOLE0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
AMRIT GODBOLE
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AMRIT GODBOLE

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients of age group between 30\-50 yrs willing to participate for the trial with a diagnosis of rheumatoid arthritis using the ACR 2010\.
  • •2\.Diagnosed cases of Amavata based on symptoms and signs described in Madhav Nidana.
  • •3\.Patients with H/O more than 1year with established disease.
  • •4\.Sero positive and Seronegative both cases are included.

Exclusion Criteria

  • •1\.Patients not willing to participate.
  • •2\.Patients with a short history of less than a year.
  • •3\.Patients having severe deformities.
  • •4\.Patients of Rheumatic Arthritis, Gouty Arthritis, Infective Arthritis, Osteoarthritis.
  • •5\.HIV, Tuberculosis, Hypertension, D.M., and other systemic problems.
  • •6\.Pregnant \& lactating women
  • •7\.Patients with major complications such as extra\-articular manifestations are also excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Clinical trial of CIM-Meg19 in COVID-19 patients
CTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80
Not yet recruiting
Not Applicable
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness
CTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
Completed
Phase 3
Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2020/05/025156Central Council for Research in Ayurvedic Sciences60
Completed
Phase 2
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms
CTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
Not yet recruiting
Phase 2
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19
CTRI/2020/06/026002ational Institute of Ayurveda